Neurobiology of Opioid Dependence: 5 - 5

Phase 2

Withdrawn

• Conditions: Opioid-Related Disorders

• Registration Number: NCT00000196
• Lead Sponsor: Yale University

Brief Summary

The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.

Detailed Description

Not available

Study Timeline

• Study Start: 1993-01
• Primary Completion: 1998-01
• Study Completion: 1998-01
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2013-09
• Last Update Submitted: 2015-06-02
• Last Update Posted: 2015-06-03

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Behavioral, physiological, neuroendocrine response to yohimbine

Trial Locations

Locations (1)

VA Connecticut Healthcare System; 🇺🇸 New Haven, Connecticut, United States